Evogene Ltd

EVGN05 Dec 2024
Healthcare
$1.5
+0.05 (+4.61%)
Lowest Today
$1.46
Highest Today
$1.59
Today’s Open
$1.5
Prev. Close
$1.52
52 Week High
$10.4
52 Week Low
$1.44
To Invest in Evogene Ltd

Evogene Ltd

Healthcare
EVGN05 Dec 2024
+0.05 (+4.61%)
1M
3M
6M
1Y
5Y
Low
$1.46
Day’s Range
High
$1.59
1.46
52 Week Low
$1.44
52-Week Range
52 Week High
$10.4
1.44
1 Day
-
1 Week
-9.09%
1 month return
-27.18%
3 month return
-50%
6 month return
+113.94%
1 Year return
+97.88%
3 Years return
-16.66%
5 Years return
+15.38%
10 Years return
-
Institutional Holdings
SILVERARC CAPITAL MANAGEMENT, LLC
4.53
Armistice Capital, LLC
2.87
Morgan Stanley - Brokerage Accounts
0.19
BNP Paribas Arbitrage, SA
0.18
P & S Renditefonds T
0.15
Renaissance Investment Group, LLC
0.15
MTF TR TA-Growth
0.14

Market Status

Fundamentals
Market Cap
10.98 mln
PB Ratio
4.71
PE Ratio
0
Enterprise Value
2.04 mln
Total Assets
51.1 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, gastrointestinal inflammatory related disorders, and antimicrobial resistance organisms. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.
Organisation
Evogene Ltd
Employees
142
Industry
Biotechnology
CEO
Mr. Ofer  Haviv CPA
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step